You are here

Article info

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?
Free

Authors

  • Nina Pauly Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Philipp Harter Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Florian Heitz Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Malak Moubarak Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Alexander Traut Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Sabrina Kaiser Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Beyhan Ataseven Department of Gynecology and Gynecological Oncology, Kliniken Essen Mitte, Essen, Germany Department of Obstetrics and Gynecology, University Hospital LMU Munich, Munich, Germany PubMed articlesGoogle scholar articles

Citation

Pauly N, Harter P, Heitz F, et al
2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?
International Journal of Gynecologic Cancer 2022;32:A109.

Publication history

  • First published October 20, 2022.
Online issue publication 
October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.